IN the present study we examined whether endothelin-1 stimulation of human monocytes causes release of chemotactic factors. It was found that monocytes released neutrophil-and monocyte-chemotactic activity in a dose-and time-dependent manner in response to ET-1. ET (Fig. 1B) showed that the release of NCA was significant by 1 h after addition of ET-1, with a maximal response measured after 4 h, and a further increase after 24 h stimulation.
Introduction
Endothelin-1 is a 21-amino acid peptide, initially isolated from endothelial cells and described as the most potent biological vasoconstrictor known.
1," It has recently been shown that ET-1 also might activate monocytes and macrophages, causing release of tumour necrosis factor-(x (TNF00, interleukin-l (IL-11) and interleukin-6 (IL-6).
When activated, monocytes release several chemotactic factors for monocytes and neutrophils. Some chemotactic factors such as TNF0t and leukotriene B (LTB4) show chemotactic activity for both monocytes and neutrophils, 4, 5 while interleukin-8 (IL-8) has chemotactic activity for neutrophils and lymphocytes, but not for monocytes6. Monocyte chemotactic protein-1 (MCP-1) has specific chemotactic and activating activity for monocytes.7
To further examine the pro-inflammatory effects of ET-1, human monocytes in vitro were stimulated with ET-1 for different time intervals, and the supernatants tested for monocyte-and neutrophil chemotactic activity. To identify the factors responsible for the chemotactic activity, neutralization experiments with antibodies against known chemotactic factors were performed. For comparison, supernatants from ET-1 stimulated human endothelial cells were also tested for chemotactic activity.
Methods
Isolation and cultivation of monocytes Highly purified monocytes were obtained using the method described previously*. Briefly, unseparated mononuclear cells (PBMC) were isolated from human A blood buffy coat (Fig. 1B) showed that the release of NCA was significant by 1 h after addition of ET-1, with a maximal response measured after 4 h, and a further increase after 24 h stimulation.
Monocytes released MCA in response to ET-1 in a dose dependent manner as shown in Fig. 2A (Fig. 3) . The migration after addition of antibody was not significantly different from controls incubated with medium only; 22_+ 3 cells/HPF. Higher antibody concentrations did not increase the inhibition of NCA, while lower antibody concentrations showed a significant reduction in inhibitory effect (data not shown). Release of IL-8 from ET-1 stimulated monocytes was further confirmed using IL-8 ELISA as shown in Table 1 .
Incubation with a monoclonal antibody against MCP-1 (dilution 1/200) reduced MCA by > 80% (Fig.  4) . The Endothelin-1 stimulates monocytes to release chemotactic activity 18, 23, 24 To conclude, ET-1 stimulation of human monocytes in vitro caused release of monocyte and neutrophil chemotactic activity provided that an intact lipoxygenase pathway was present. The neutrophil-and monocyte chemotactic activity were identified as IL-8 and MCP-1, respectively.
